286 related articles for article (PubMed ID: 23365078)
1. Tissue-specific host recognition by complement factor H is mediated by differential activities of its glycosaminoglycan-binding regions.
Clark SJ; Ridge LA; Herbert AP; Hakobyan S; Mulloy B; Lennon R; Würzner R; Morgan BP; Uhrín D; Bishop PN; Day AJ
J Immunol; 2013 Mar; 190(5):2049-57. PubMed ID: 23365078
[TBL] [Abstract][Full Text] [Related]
2. Impaired binding of the age-related macular degeneration-associated complement factor H 402H allotype to Bruch's membrane in human retina.
Clark SJ; Perveen R; Hakobyan S; Morgan BP; Sim RB; Bishop PN; Day AJ
J Biol Chem; 2010 Sep; 285(39):30192-202. PubMed ID: 20660596
[TBL] [Abstract][Full Text] [Related]
3. The role of complement in age-related macular degeneration: heparan sulphate, a ZIP code for complement factor H?
Langford-Smith A; Keenan TD; Clark SJ; Bishop PN; Day AJ
J Innate Immun; 2014; 6(4):407-16. PubMed ID: 24335201
[TBL] [Abstract][Full Text] [Related]
4. Complement factor H and age-related macular degeneration: the role of glycosaminoglycan recognition in disease pathology.
Clark SJ; Bishop PN; Day AJ
Biochem Soc Trans; 2010 Oct; 38(5):1342-8. PubMed ID: 20863311
[TBL] [Abstract][Full Text] [Related]
5. Disease-linked mutations in factor H reveal pivotal role of cofactor activity in self-surface-selective regulation of complement activation.
Kerr H; Wong E; Makou E; Yang Y; Marchbank K; Kavanagh D; Richards A; Herbert AP; Barlow PN
J Biol Chem; 2017 Aug; 292(32):13345-13360. PubMed ID: 28637873
[TBL] [Abstract][Full Text] [Related]
6. Heparan sulfate, including that in Bruch's membrane, inhibits the complement alternative pathway: implications for age-related macular degeneration.
Kelly U; Yu L; Kumar P; Ding JD; Jiang H; Hageman GS; Arshavsky VY; Frank MM; Hauser MA; Rickman CB
J Immunol; 2010 Nov; 185(9):5486-94. PubMed ID: 20876352
[TBL] [Abstract][Full Text] [Related]
7. Selective Binding of Heparin/Heparan Sulfate Oligosaccharides to Factor H and Factor H-Related Proteins: Therapeutic Potential for C3 Glomerulopathies.
Loeven MA; Maciej-Hulme ML; Yanginlar C; Hubers MC; Kellenbach E; de Graaf M; van Kuppevelt TH; Wetzels J; Rabelink TJ; Smith RJH; van der Vlag J
Front Immunol; 2021; 12():676662. PubMed ID: 34489931
[TBL] [Abstract][Full Text] [Related]
8. Recognition of malondialdehyde-modified proteins by the C terminus of complement factor H is mediated via the polyanion binding site and impaired by mutations found in atypical hemolytic uremic syndrome.
Hyvärinen S; Uchida K; Varjosalo M; Jokela R; Jokiranta TS
J Biol Chem; 2014 Feb; 289(7):4295-306. PubMed ID: 24344133
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous hemolytic uremic syndrome triggered by complement factor H lacking surface recognition domains.
Pickering MC; de Jorge EG; Martinez-Barricarte R; Recalde S; Garcia-Layana A; Rose KL; Moss J; Walport MJ; Cook HT; de Córdoba SR; Botto M
J Exp Med; 2007 Jun; 204(6):1249-56. PubMed ID: 17517971
[TBL] [Abstract][Full Text] [Related]
10. Complement factor H variants I890 and L1007 while commonly associated with atypical hemolytic uremic syndrome are polymorphisms with no functional significance.
Tortajada A; Pinto S; Martínez-Ara J; López-Trascasa M; Sánchez-Corral P; de Córdoba SR
Kidney Int; 2012 Jan; 81(1):56-63. PubMed ID: 21881555
[TBL] [Abstract][Full Text] [Related]
11. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
Francis NJ; McNicholas B; Awan A; Waldron M; Reddan D; Sadlier D; Kavanagh D; Strain L; Marchbank KJ; Harris CL; Goodship TH
Blood; 2012 Jan; 119(2):591-601. PubMed ID: 22058112
[TBL] [Abstract][Full Text] [Related]
12. Identification of factor H-like protein 1 as the predominant complement regulator in Bruch's membrane: implications for age-related macular degeneration.
Clark SJ; Schmidt CQ; White AM; Hakobyan S; Morgan BP; Bishop PN
J Immunol; 2014 Nov; 193(10):4962-70. PubMed ID: 25305316
[TBL] [Abstract][Full Text] [Related]
13. The endothelial glycocalyx as a potential modifier of the hemolytic uremic syndrome.
Boels MG; Lee DH; van den Berg BM; Dane MJ; van der Vlag J; Rabelink TJ
Eur J Intern Med; 2013 Sep; 24(6):503-9. PubMed ID: 23357408
[TBL] [Abstract][Full Text] [Related]
14. Age-dependent changes in heparan sulfate in human Bruch's membrane: implications for age-related macular degeneration.
Keenan TD; Pickford CE; Holley RJ; Clark SJ; Lin W; Dowsey AW; Merry CL; Day AJ; Bishop PN
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5370-9. PubMed ID: 25074778
[TBL] [Abstract][Full Text] [Related]
15. Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.
Herbert AP; Deakin JA; Schmidt CQ; Blaum BS; Egan C; Ferreira VP; Pangburn MK; Lyon M; Uhrín D; Barlow PN
J Biol Chem; 2007 Jun; 282(26):18960-8. PubMed ID: 17360715
[TBL] [Abstract][Full Text] [Related]
16. Human complement factor H Y402H polymorphism causes an age-related macular degeneration phenotype and lipoprotein dysregulation in mice.
Landowski M; Kelly U; Klingeborn M; Groelle M; Ding JD; Grigsby D; Bowes Rickman C
Proc Natl Acad Sci U S A; 2019 Feb; 116(9):3703-3711. PubMed ID: 30808757
[TBL] [Abstract][Full Text] [Related]
17. Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro.
Loeven MA; Rops AL; Lehtinen MJ; van Kuppevelt TH; Daha MR; Smith RJ; Bakker M; Berden JH; Rabelink TJ; Jokiranta TS; van der Vlag J
J Biol Chem; 2016 Mar; 291(10):4974-81. PubMed ID: 26728463
[TBL] [Abstract][Full Text] [Related]
18. Dual roles of different redox forms of complement factor H in protecting against age related macular degeneration.
Krilis M; Qi M; Qi J; Wong JWH; Guymer R; Liew G; Hunyor AP; Madigan M; McCluskey P; Weaver J; Krilis SA; Giannakopoulos B
Free Radic Biol Med; 2018 Dec; 129():237-246. PubMed ID: 30253188
[TBL] [Abstract][Full Text] [Related]
19. Mutations of factor H impair regulation of surface-bound C3b by three mechanisms in atypical hemolytic uremic syndrome.
Lehtinen MJ; Rops AL; Isenman DE; van der Vlag J; Jokiranta TS
J Biol Chem; 2009 Jun; 284(23):15650-8. PubMed ID: 19351878
[TBL] [Abstract][Full Text] [Related]
20. Nitration of tyrosines in complement factor H domains alters its immunological activity and mediates a pathogenic role in age related macular degeneration.
Krilis M; Qi M; Madigan MC; Wong JWH; Abdelatti M; Guymer RH; Whitelock J; McCluskey P; Zhang P; Qi J; Hunyor AP; Krilis SA; Giannakopoulos B
Oncotarget; 2017 Jul; 8(30):49016-49032. PubMed ID: 28159936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
